Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study) – European Respiratory Journal Commentary: Exacerbations Increased After Discontinuing Long-term Use of Mepolizumab for Severe Eosinophilic Asthma – Consultant 360   Commentary on Twitter This randomised study demonstrates increased exacerbation risk and a decrease in asthma control in patients with severe eosinophilic asthma who stop […]

The post RCT | Stopping vs. continuing long-term mepolizumab treatment in severe eosinophilic asthma. appeared first on Links Medicus.